George Golumbeski Insider Trading $ENTA ENANTA PHARMACEUTICALS INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for George Golumbeski.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of George Golumbeski. George Golumbeski is Director in ENANTA PHARMACEUTICALS INC ($ENTA) and Director in Corbus Pharmaceuticals Holdings, Inc. ($CRBP) and in Sage Therapeutics, Inc. ($SAGE) and Director in Shattuck Labs, Inc. ($STTK).

George Golumbeski in ENANTA PHARMACEUTICALS INC

Trading Symbol: ENTA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of George Golumbeski: Director
Holdings: 9,280 shares
Current Value: $298,816
Latest Transaction: Feb 28 2020
$ENTA Market Capitalization: $593.41M
$ENTA Previous Close: $32.20

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of George Golumbeski in ENANTA PHARMACEUTICALS INC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, CRBP, ENTA, SAGE, STTK

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 28 2020ENTAENANTA PHARMACEUTI ...Golumbeski GeorgeDirectorOption ExerciseA51.0410,000510,40010,000
Mar 06 2019ENTAENANTA PHARMACEUTI ...Golumbeski GeorgeDirectorOption ExerciseM36.619,280339,7410
Mar 06 2019ENTAENANTA PHARMACEUTI ...Golumbeski GeorgeDirectorSellS103.659,280961,89709.3 K to 0 (-100.00 %)
Mar 06 2019ENTAENANTA PHARMACEUTI ...Golumbeski GeorgeDirectorBuyM36.619,280339,7419,2800 to 9.3 K
Mar 06 2019ENTAENANTA PHARMACEUTI ...Golumbeski GeorgeDirectorOption ExerciseM36.619,280339,7410
Mar 06 2019ENTAENANTA PHARMACEUTI ...Golumbeski GeorgeDirectorSellS103.659,280961,89709.3 K to 0 (-100.00 %)
Mar 06 2019ENTAENANTA PHARMACEUTI ...Golumbeski GeorgeDirectorBuyM36.619,280339,7419,2800 to 9.3 K
Mar 01 2019ENTAENANTA PHARMACEUTI ...Golumbeski GeorgeDirectorOption ExerciseA102.545,000512,7005,000
Feb 13 2019ENTAENANTA PHARMACEUTI ...Golumbeski GeorgeDirectorOption ExerciseM29.027,500217,6500
Feb 13 2019ENTAENANTA PHARMACEUTI ...Golumbeski GeorgeDirectorOption ExerciseM25.583,72895,3620
Feb 13 2019ENTAENANTA PHARMACEUTI ...Golumbeski GeorgeDirectorOption ExerciseM25.582,27258,1183,728
Feb 13 2019ENTAENANTA PHARMACEUTI ...Golumbeski GeorgeDirectorSellS90.0711,2281,011,301011.2 K to 0 (-100.00 %)
Feb 13 2019ENTAENANTA PHARMACEUTI ...Golumbeski GeorgeDirectorBuyM29.027,500217,65011,2283.7 K to 11.2 K (+201.18 %)
Feb 13 2019ENTAENANTA PHARMACEUTI ...Golumbeski GeorgeDirectorBuyM25.583,72895,3623,7280 to 3.7 K
Feb 13 2019ENTAENANTA PHARMACEUTI ...Golumbeski GeorgeDirectorSellS90.032,272204,55202.3 K to 0 (-100.00 %)
Feb 13 2019ENTAENANTA PHARMACEUTI ...Golumbeski GeorgeDirectorBuyM25.582,27258,1182,2720 to 2.3 K
Mar 05 2018ENTAENANTA PHARMACEUTI ...Golumbeski GeorgeDirectorOption ExerciseA78.627,500589,6507,500
Feb 21 2017ENTAENANTA PHARMACEUTI ...Golumbeski GeorgeDirectorOption ExerciseA29.027,500217,6507,500
Feb 12 2016ENTAENANTA PHARMACEUTI ...Golumbeski GeorgeDirectorOption ExerciseA25.586,000153,4806,000

Page:   1